Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention

NCT07449247 is registered in ClinicalTrials.gov with Tianjin Medical University Eye Hospital as lead sponsor.

NCT NCT07449247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07449247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention
Lead sponsor
Tianjin Medical University Eye Hospital
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
March 30, 2026
Completion date
June 30, 2027
Enrollment
233 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pre-myopia